Results 21 to 30 of about 11,469 (180)

More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery [PDF]

Asian Spine Journal, 2015
Study DesignRetrospective case series.PurposeTo examine the most effective duration of teriparatide use for spinal fusion in women with postmenopausal osteoporosis.Overview of LiteratureWe reported that daily subcutaneous injection of teriparatide ...
Seiji Ohtori, Sumihisa Orita, Kazuyo Yamauchi, Yawara Eguchi, Nobuyasu Ochiai, Kazuki Kuniyoshi, Yasuchika Aoki, Junichi Nakamura, Masayuki Miyagi, Miyako Suzuki, Gou Kubota, Kazuhide Inage, Takeshi Sainoh, Jun Sato, Yasuhiro Shiga, Koki Abe, Kazuki Fujimoto, Hiroto Kanamoto, Gen Inoue, Kazuhisa Takahashi   +19 more
doaj   +1 more source

Does Discontinuing Teriparatide Treatment and Replacing It with Bisphosphonate Maintain the Volume of the Bone Fusion Mass after Lumbar Posterolateral Fusion in Women with Postmenopausal Osteoporosis? [PDF]

Asian Spine Journal, 2017
Study DesignRetrospective case series.PurposeThe purpose of this study was to determine whether discontinuing teriparatide treatment and replacing it with bisphosphonate treatment maintains the volume of the fusion mass after posterolateral fusion (PLF ...
Seiji Ohtori, Sumihisa Orita, Kazuyo Yamauchi, Yawara Eguchi, Yasuchika Aoki, Junichi Nakamura, Miyako Suzuki, Gou Kubota, Kazuhide Inage, Yasuhiro Shiga, Koki Abe, Kazuki Fujimoto, Hirohito Kanamoto, Masahiro Inoue, Hideyuki Kinoshita, Takeo Furuya, Masao Koda   +16 more
doaj   +1 more source

Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis

Journal of Orthopaedic Surgery and Research, 2023
Background Continuous use of glucocorticoids (GCs) has become the primary cause of secondary osteoporosis. Bisphosphonate drugs were given priority over denosumab and teriparatide in the 2017 American College of Rheumatology (ACR) guidelines but have a ...
Chuanjian Yuan, Yanchen Liang, Kai Zhu, Wenpeng Xie   +3 more
doaj   +1 more source

Effectiveness of Teriparatide on Fracture Healing: A Systematic Review and Meta-Analysis.

PLoS ONE, 2016
PurposeNowadays, the efficacy of teriparatide in treating osteoporosis was widely accepted, but the discussion about using teriparatide to enhance fracture healing hasn't come to an agreement.
Zhongju Shi, Hengxing Zhou, Bin Pan, Lu Lu, Jun Liu, Yi Kang, Xue Yao, Shiqing Feng   +7 more
doaj   +1 more source

Indications to teriparatide treatment in patients with osteoporosis

, 2011
To prevent osteoporotic fracture occurrence, a variety of treatment regimens with different mechanisms of action is available. The antiresorptive bisphosphonate drugs are currently the most commonly prescribed agents in the management of patients with ...
M Kraenzlin, K Lippuner, Rizzoli, R, Lamy, O., O Lamy, Kraenzlin, M., HU Mellinghoff, Kraenzlin, M, R Rizzoli, Rizzoli, R., Lamy, O, Krieg, M. A., Mellinghoff, H U, Krieg, MA, MA Krieg, Mellinghoff, HU, Mellinghoff, H. U., Krieg, M A, Lippuner, K., Rizzoli, René, Lippuner, K   +20 more
core   +2 more sources

Malignant Myeloma in a Patient after Treatment for Osteoporosis with Teriparatide; a Rare Coincidence

Clinical Medicine Insights: Case Reports, 2008
A breakthrough in understanding of mechanisms of bone structure regulation has brought about the introduction of the new synthetic recombinant human parathyroid hormone 1–34 (PTH1-34; Teriparatide) in the treatment of osteoporosis.
Terje Forslund, Anna-Mari Koski, Arvo Koistinen, Anu Sikiö   +3 more
doaj   +1 more source

Does Early Treatment With Teriparatide Prevent the Need for Surgical Intervention in Osteoporotic Vertebral Compression Fractures

Global Spine Journal
Study Design Retrospective Cohort Study. Objective The primary objective of this study is to evaluate the efficacy of early administration of Teriparatide in preventing the necessity of surgical intervention in individuals with osteoporotic vertebral ...
Vishnu Vikraman Nair MBBS, MS, Vishal Kundnani MS   +1 more
doaj   +1 more source

Pregnancy‐ and lactation‐associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Pregnancy‐ and lactation‐associated osteoporosis (PLO) is a syndrome characterized by fragility fractures (most commonly vertebral, often multiple) occurring in late pregnancy or the early postpartum period. This position statement summarizes the current knowledge of PLO, and the recommended procedure for assessment, diagnosis and treatment ...
Peyman Hadji, Apostolos Athanasiadis, Maria‐Luisa Brandi, Marlene Chakhtoura, Manju Chandran, Frank Chervenak, Amos Grünebaum, Irene Lambrinoudaki, Willem F. Lems, Apostolos M. Mamopoulos, Eugene McCloskey, Rossella E. Nappi, Jessica Pepe, Jean‐Yves Reginster, René Rizzoli, Petra Stute, Şansın Tuzun, Amanda J. Vincent, Maria Belen Zanchetta, M. Carola Zillikens, Ioannis Kyvernitakis   +20 more
wiley   +1 more source

Preliminary effects of weekly teriparatide for prevention of knee osteoarthritis progression: a pilot randomized controlled trial

Journal of Joint Surgery and Research
Purpose: Subchondral bone fragility contributes to disease progression in knee osteoarthritis (KOA), particularly in osteoporosis. Teriparatide improves subchondral bone quality and shows disease-modifying effects in pre-clinical KOA models, but its ...
Kazuki Ichiyanagi, Shigeo Yoshida, Moritoshi Furu, Yugo Morita, Taizo Furukawa, Shunichi Shimamura, Takuhiro Yoshikawa, Makoto Takahashi, Takeo Tsuji, Yasushi Taguchi, Nobumi Takeda, Masayuki Azukizawa, Mutsumi Watanabe, Yugo Morita, Takahiro Maeda, Sayoko Sakai, Shinichiro Nakamura, Shinichi Kuriyama, Hiromu Ito, Kohei Nishitani   +19 more
doaj   +1 more source

Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment

BMC Musculoskeletal Disorders, 2017
Background Atypical subtrochanteric fracture and femoral fracture have been considered to be rare complications related to long-term bisphosphonates use. A reduced bone turnover rate may lead to delayed bone healing.
Wen-Ling Yeh, Chun-Yi Su, Chia-Wei Chang, Chien-Hao Chen, Tsai-Sheng Fu, Lih-Huei Chen, Tung-Yi Lin   +6 more
doaj   +1 more source